Advertisement
The American Journal of Cardiology®
Advanced SearchSave search
Roundtable discussion| Volume 110, ISSUE 6, P807-816, September 15, 2012

The Editor's Roundtable: Advances in Stem Cell Therapy for Treatment of Cardiovascular Disease

Published:July 23, 2012DOI:https://doi.org/10.1016/j.amjcard.2012.06.046
The Editor's Roundtable: Advances in Stem Cell Therapy for Treatment of Cardiovascular Disease
Previous ArticleTreatment Strategies for Acute Coronary Syndrome With Severe Mitral Regurgitation and Their Effects on Short- and Long-Term Prognosis
Next ArticleEffectiveness and Safety of Laropiprant on Niacin-Induced Flushing
      This article is supported by a grant from the Okyanos Heart Institute, Freeport, The Bahamas.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Strauer B.E.
        • Brehm M.
        • Zeus T.
        • Kostering M.
        • Hernandez A.
        • Sorg R.V.
        • Kogler G.
        • Wernet P.
        Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
        Circulation. 2002; 106: 1913-1918
        View in Article
        • Perin E.C.
        • Dohmann H.F.
        • Borojevic R.
        • Silva S.A.
        • Sousa A.L.
        • Mesquita C.T.
        • Rossi M.I.
        • Carvalho A.C.
        • Dutra H.S.
        • Dohmann H.J.
        • Silva G.V.
        • Belem L.
        • Vivacqua R.
        • Rangel F.O.
        • Esporcatte R.
        • Geng Y.J.
        • Vaughn W.K.
        • Assad J.A.
        • Mesquita E.T.
        • Willerson J.T.
        Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
        Circulation. 2003; 107: 2294-2302
        View in Article
        • Foldes G.
        • Harding S.E.
        Stem Cell Therapy to Treat Heart Failure.
        in: 2nd ed. Elsevier, New York2011: 407-423
        View in Article
        • Strauer B.-E.
        • Steinhoff G.
        10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart.
        J Am Coll Cardiol. 2011; 58: 1095-1104
        View in Article
        • Heldman A.W.
        • Zambrano J.P.
        • Hare J.
        Cell therapy for heart disease. Where are we in 2011?.
        J Am Coll Cardiol. 2011; 57: 466-468
        View in Article
        • Blum B.
        • Benvenisty N.
        The tumorigenicity of human embryonic stem cells.
        Adv Cancer Res. 2008; 100: 133-158
        View in Article
        • Aggarwal S.
        • Pittenger M.F.
        Human mesenchymal stem cells moderate allogenic immune cell responses.
        Blood. 2005; 105: 1815-1822
        View in Article
        • Makkar R.R.
        • Smith R.R.
        • Cheng K.
        • Malliaras K.
        • Thomson L.E.J.
        • Berman D.
        • Czer L.S.C.
        • Marban L.
        • Mendizabal A.
        • Johnston
        • Russell S.D.
        • Schuleri K.H.
        • Lardo A.C.
        • Gerstenblith G.
        • Marbán MD, E.
        Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.
        Lancet. 2012; 379: 895-904
        View in Article
        • Davis D.R.
        • Smith R.R.
        • Marbán E.
        Human cardiospheres are a source of stem cells with cardiomyogenic potential.
        Stem Cells. 2010; 28: 903-904
        View in Article
        • Bolli R.
        • Chugh A.R.
        • D'Amario D.
        • Laughran J.H.
        • Stoddard M.F.
        • Ikram S.
        • Beache G.M.
        • Wagner S.G.
        • Leri A.
        • Hosoda T.
        • Sanada F.
        • Elmore J.B.
        • Goichberg P.
        • Cappetta D.
        • Solakhi N.K.
        • Fahsah I.
        • Rokosh D.G.
        • Slaughter M.S.
        • Kajusta J.
        • Anversa P.
        Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomized phase 1 trial.
        Lancet. 2011; 378: 1847-1857
        View in Article
        • Small E.M.
        • Thatcher J.E.
        • Sutherland L.B.
        • Kinoshita H.
        • Gerard R.D.
        • Richardson J.A.
        • DiMaio J.M.
        • Sadek H.
        • Kuwahara K.
        • Olson E.N.
        Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction.
        Circ Res. 2010; 107: 294-304
        View in Article
        • Beltrami A.P.
        • Barlucchi L.
        • Torella D.
        • Baker M.
        • Limana F.
        • Chimenti S.
        • Kasahara H.
        • Rota M.
        • Musso E.
        • Urbanek K.
        • Leri A.
        • Kajstura J.
        • Nadal-Ginard B.
        • Anversa P.
        Adult cardiac stem cells are multipotent and support myocardial regeneration.
        Cell. 2003; 114: 763-776
        View in Article
        • Askari A.T.
        • Unzek S.
        • Popovic Z.B.
        • Goldman C.K.
        • Forudi F.
        • Kiedrowski M.
        • Rovner A.
        • Ellis S.G.
        • Thomas J.D.
        • DiCorleto P.E.
        • Topol E.J.
        • Penn M.S.
        Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
        Lancet. 2003; 362: 697-703
        View in Article
        • Menon V.
        • Pearte C.A.
        • Buller C.E.
        • Steg G.
        • Forman S.A.
        • White H.D.
        • Marino P.N.
        • Katritsis D.G.
        • Caramori P.
        • Lasevitch R.
        • Loboz-Grudzien K.
        • Zurakowski A.
        • Lamas G.A.
        • Hochman J.S.
        Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
        Eur Heart J. 2009; 30: 183-191
        View in Article
        • Perin E.C.
        • Willerson J.T.
        • Pepine C.J.
        • Henry T.D.
        • Ellis S.G.
        • Zhao D.X.
        • Silva G.V.
        • Lai D.
        • Thomas J.D.
        • Kronenberg M.W.
        • Martin A.D.
        • Anderson R.D.
        • Traverse J.H.
        • Penn M.S.
        • Anwaruddin S.
        • Hatzopoulos A.K.
        • Gee A.P.
        • Taylor D.A.
        • Cogle C.R.
        • Smith D.
        • Westbrook L.
        • Handberg E.
        • Olson R.E.
        • Geither C.
        • Bowman S.
        • Francescon J.
        • Baraniuk S.
        • Piller L.B.
        • Simpson L.M.
        • Loghin C.
        • Aguilar D.
        • Richman S.
        • Zierold C.
        • Bettencourt J.
        • Sayre S.L.
        • Vojvodic R.W.
        • Skarlatos S.I.
        • Gordon D.J.
        • Ebert R.F.
        • Kwak M.
        • Moyé L.A.
        • Simari R.D.
        • Cardiovascular Cell Therapy Research Network
        Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
        JAMA. 2012; 307: 1717-1726
        View in Article
        • Tan J.
        • Wu W.
        • Xu X.
        • Liao L.
        • Zheng F.
        • Messinger S.
        • Sun X.
        • Chen J.
        • Yang S.
        • Cai J.
        • Gao X.
        • Pileggi A.
        • Ricordi C.
        Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.
        JAMA. 2012; 307: 1169-1177
        View in Article
        • Wang W.
        • Lang J.K.
        • Suzuki G.
        • Canty J.M.
        • Cimato T.
        Statins enhance clonal growth of late outgrowth endothelial progenitors and increase myocardial capillary density in the chronically ischemic heart.
        PLoS One. 2011; 6: e24868
        View in Article
        • Menasche P.
        Stem cell therapy for heart failure.
        Circulation. 2009; 119: 2735-2740
        View in Article
        • Hare J.M.
        • Traverse J.H.
        • Henry T.D.
        • Dib N.
        • Strumpf R.K.
        • Schulman S.P.
        • Gerstenblith G.
        • DeMaria A.N.
        • Denktas A.E.
        • Gammon R.S.
        • Hermiller Jr, J.B.
        • Reisman M.A.
        • Schaer G.L.
        • Sherman W.
        A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
        J Am Coll Cardiol. 2009; 54: 2277-2286
        View in Article
        • Stewart S.
        • MacIntyre K.
        • Hole D.J.
        • Capewell S.
        • McMurray J.J.V.
        More “malignant” than cancer?.
        Eur Heart Fail. 2001; 3: 315-322
        View in Article

      Article Info

      Publication History

      Published online: July 23, 2012

      Footnotes

      This article is based on a discussion among the faculty on March 26, 2012 (Chicago, Illinois).

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2012.06.046

      Copyright

      © 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX